What is the role of participation in a clinical trial in the treatment of Sezary syndrome and erythrodermic mycosis fungoides cutaneous T-cell lymphoma (CTCL)?

Updated: Apr 20, 2020
  • Author: Lauren C Pinter-Brown, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Participation in a clinical trial as a treatment option for all patients with SS or advanced-stage MF is recommended by both the NCCN and EOTRTC.  [131, 132]  Treatment for SS or erythrodermic MF (stage IV) is palliative. The preferred modality is ECP, either alone or in combination with other treatments. [131, 132, 133]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!